About
TracerBio is a biotechnology company that develops software and platforms for decentralized, ultrasensitive detection of Minimal Residual Disease (MRD) in cancer patients using existing sequencing and dPCR devices.
Explore TracerBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.